Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.

S. aureus vaccine development has proven particularly difficult. The conventional approach to achieve sterile immunity through opsonophagocytic killing has been largely unsuccessful. S. aureus is highly toxigenic and a great body of evidence suggests that a successful future vaccine for this organis...

Full description

Bibliographic Details
Main Authors: Rajan P Adhikari, Thomas Kort, Sergey Shulenin, Tulasikumari Kanipakala, Nader Ganjbaksh, Mary-Claire Roghmann, Frederick W Holtsberg, M Javad Aman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4569305?pdf=render
id doaj-e30c3539d13c4c208ba54b1ee10590e9
record_format Article
spelling doaj-e30c3539d13c4c208ba54b1ee10590e92020-11-25T01:51:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013787410.1371/journal.pone.0137874Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.Rajan P AdhikariThomas KortSergey ShuleninTulasikumari KanipakalaNader GanjbakshMary-Claire RoghmannFrederick W HoltsbergM Javad AmanS. aureus vaccine development has proven particularly difficult. The conventional approach to achieve sterile immunity through opsonophagocytic killing has been largely unsuccessful. S. aureus is highly toxigenic and a great body of evidence suggests that a successful future vaccine for this organism should target extracellular toxins which are responsible for host tissue destruction and immunosuppression. Major staphylococcal toxins are alpha toxin (a single subunit hemolysin) along with a group of bicomponent pore-forming toxins (BCPFT), namely Panton-Valentine leukocidin (PVL), gamma hemolysins (HlgCB and AB), LukAB and LukED. In our previous report, an attenuated mutant of LukS-PV (PVL- S subunit) named as "LukS-mut9" elicited high immunogenic response as well as provided a significant protection in a mouse sepsis model. Recent discovery of PVL receptors shows that mice lack receptors for this toxin, thus the reported protection of mice with the PVL vaccine may relate to cross protective responses against other homologous toxins. This manuscript addresses this issue by demonstrating that polyclonal antibody generated by LukS-mut9 can neutralize other canonical and non-canonical leukotoxin pairs. In this report, we also demonstrated that several potent toxins can be created by non-canonical pairing of subunits. Out of 5 pairs of canonical and 8 pairs of non-canonical toxins tested, anti-LukS-mut9 polyclonal antibodies neutralized all except for LukAB. We also studied the potential hemolytic activities of canonical and noncanonical pairs among biocomponent toxins and discovered that a novel non-canonical pair consisting of HlgA and LukD is a highly toxic combination. This pair can lyse RBC from different species including human blood far better than alpha hemolysin. Moreover, to follow-up our last report, we explored the correlation between the levels of pre-existing antibodies to new sets of leukotoxins subunits and clinical outcomes in adult patients with S. aureus bacteremia. We found that there is an inversed correlation between the antibody titer to sepsis for leukotoxins LukS-mut9, LukF-PV, HlgC, LukE and LukAB, suggesting the risk of sepsis was significantly lower in the patients with higher antibody titer against those toxins.http://europepmc.org/articles/PMC4569305?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Rajan P Adhikari
Thomas Kort
Sergey Shulenin
Tulasikumari Kanipakala
Nader Ganjbaksh
Mary-Claire Roghmann
Frederick W Holtsberg
M Javad Aman
spellingShingle Rajan P Adhikari
Thomas Kort
Sergey Shulenin
Tulasikumari Kanipakala
Nader Ganjbaksh
Mary-Claire Roghmann
Frederick W Holtsberg
M Javad Aman
Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
PLoS ONE
author_facet Rajan P Adhikari
Thomas Kort
Sergey Shulenin
Tulasikumari Kanipakala
Nader Ganjbaksh
Mary-Claire Roghmann
Frederick W Holtsberg
M Javad Aman
author_sort Rajan P Adhikari
title Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
title_short Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
title_full Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
title_fullStr Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
title_full_unstemmed Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
title_sort antibodies to s. aureus luks-pv attenuated subunit vaccine neutralize a broad spectrum of canonical and non-canonical bicomponent leukotoxin pairs.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description S. aureus vaccine development has proven particularly difficult. The conventional approach to achieve sterile immunity through opsonophagocytic killing has been largely unsuccessful. S. aureus is highly toxigenic and a great body of evidence suggests that a successful future vaccine for this organism should target extracellular toxins which are responsible for host tissue destruction and immunosuppression. Major staphylococcal toxins are alpha toxin (a single subunit hemolysin) along with a group of bicomponent pore-forming toxins (BCPFT), namely Panton-Valentine leukocidin (PVL), gamma hemolysins (HlgCB and AB), LukAB and LukED. In our previous report, an attenuated mutant of LukS-PV (PVL- S subunit) named as "LukS-mut9" elicited high immunogenic response as well as provided a significant protection in a mouse sepsis model. Recent discovery of PVL receptors shows that mice lack receptors for this toxin, thus the reported protection of mice with the PVL vaccine may relate to cross protective responses against other homologous toxins. This manuscript addresses this issue by demonstrating that polyclonal antibody generated by LukS-mut9 can neutralize other canonical and non-canonical leukotoxin pairs. In this report, we also demonstrated that several potent toxins can be created by non-canonical pairing of subunits. Out of 5 pairs of canonical and 8 pairs of non-canonical toxins tested, anti-LukS-mut9 polyclonal antibodies neutralized all except for LukAB. We also studied the potential hemolytic activities of canonical and noncanonical pairs among biocomponent toxins and discovered that a novel non-canonical pair consisting of HlgA and LukD is a highly toxic combination. This pair can lyse RBC from different species including human blood far better than alpha hemolysin. Moreover, to follow-up our last report, we explored the correlation between the levels of pre-existing antibodies to new sets of leukotoxins subunits and clinical outcomes in adult patients with S. aureus bacteremia. We found that there is an inversed correlation between the antibody titer to sepsis for leukotoxins LukS-mut9, LukF-PV, HlgC, LukE and LukAB, suggesting the risk of sepsis was significantly lower in the patients with higher antibody titer against those toxins.
url http://europepmc.org/articles/PMC4569305?pdf=render
work_keys_str_mv AT rajanpadhikari antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
AT thomaskort antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
AT sergeyshulenin antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
AT tulasikumarikanipakala antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
AT naderganjbaksh antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
AT maryclaireroghmann antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
AT frederickwholtsberg antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
AT mjavadaman antibodiestosaureuslukspvattenuatedsubunitvaccineneutralizeabroadspectrumofcanonicalandnoncanonicalbicomponentleukotoxinpairs
_version_ 1724996106122690560